Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by jag009  – NJ, 2020-02-04 19:43 (236 d 23:03 ago) – Posting: # 21145
Views: 1,063

» We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.
»
» Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Not sure if this answers your question(I think so but..):
Why not? For both safety and bioanalytical reasons.

J

Complete thread:

Activity
 Admin contact
21,084 posts in 4,398 threads, 1,468 registered users;
online 6 (0 registered, 6 guests [including 5 identified bots]).
Forum time: Monday 19:46 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5